CONMED Corp. (CNMD)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 06, 2025

$68.58

P/E Ratio

16.26

Market Cap

$2.12B

Loading...
Description

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Metrics

Overview

  • HQLargo, FL
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerCNMD
  • Price$68.58+0.93%

Trading Information

  • Market cap$2.12B
  • Float97.22%
  • Average Daily Volume (1m)402,134
  • Average Daily Volume (3m)409,573
  • EPS$4.28

Company

  • Revenue$1.28B
  • Rev growth (1yr)4.27%
  • Net income$48.98M
  • Gross margin53.70%
  • EBITDA margin16.37%
  • EBITDA$51.79M
  • EV$3.14B
  • EV/Revenue2.44
  • P/E16.26
  • P/S1.66
  • P/B2.27
Documents